Bringing NHS data analysis into the 21st century by Goldacre, Ben, Bardsley, Martin, Benson, Tim, Cheema, Kate, Chinn, Roger, Coughlan, Ellen, Dougan, Sarah, Farr, Marc, Hawkins, Loraine, Jonas, Adrian, Kinnear, Andy, Mcinnes, Morag, Mohammed, Mohammed Amin, Morton, Caroline, Pasumarthy, Rahul, Pettinger, Neil, Rowland, Ben, Sebire, Neil, Stroner, Paul, Tennison, Jeni, Warnakula, Samantha, Watson, Oliver, Wright, Emma, Young, Hamish, Morley, Jessica

Get full text

The perils of a sound-bite health policy.(United Kingdom National Health Service) by Pettinger, Neil

Get full text

The perils of a sound-bite health policy by Pettinger, Neil

Get full text

Do we need so many doctors? by Pettinger, Neil

Get full text

Casualty! The carer of last resort. (Scotland health service) by Pettinger, Neil

Get full text

Casualty! The carer of last resort by Pettinger, Neil

Get full text

A NIGHT AT THE OPERA by Pettinger, Neil

Get full text

Do we need so many doctors? (impact of the increased number of doctors in the UK) by Pettinger, Neil

Get full text

What does ‘co‐production’ look like for food system transformation? Mapping the evidence across Transforming UK Food Systems (TUKFS) projects by Shaw, Naomi, Hardman, Charlotte A., Boyle, Neil Bernard, Craven, Joanne, Dooley, John, Mead, Bethan R., Morgans, Lisa, Mumby, Hannah, Pettinger, Clare

Get full text

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (C... by Shanafelt, Tait D., Ramsay, Alan G., Zent, Clive S., Leis, Jose F., Tun, Han W., Call, Timothy G., LaPlant, Betsy, Bowen, Deborah, Pettinger, Adam, Jelinek, Diane F., Hanson, Curtis A., Kay, Neil E.

Get full text

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia by Kay, Neil E, Strati, Paolo, LaPlant, Betsy R, Leis, Jose F, Nikcevich, Daniel, Call, Timothy G, Pettinger, Adam M, Lesnick, Connie E, Hanson, Curtis A, Shanafelt, Tait D

Get full text

Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study by Larsen, Jeremy T., Shanafelt, Tait D., Leis, Jose F., LaPlant, Betsy, Call, Tim, Pettinger, Adam, Hanson, Curtis, Erlichman, Charles, Habermann, Thomas Matthew, Reeder, Craig, Nikcevich, Daniel, Bowen, Deborah, Conte, Michael, Boysen, Justin, Secreto, Charla, Lesnick, Connie, Tschumper, Renee, Jelinek, Diane, Kay, Neil E., Ding, Wei

Get full text

Abstract 1423: The addition of bevacizumab to chemoimmunotherapy prolongs progression-free survival in patients with chronic lymphocytic leukemia (CLL) through modulation of the mi... by STRATI, PAOLO, SHANAFELT, TAIT D., LAPLANT, BETSY, PETTINGER, ADAM, LESNICK, CONNIE, NIKCEVICH, DANIEL, CALL, TIMOTHY, DING, WEI, HANSON, CURTIS, KAY, NEIL

Get full text

The genomic landscape of lung cancer in never-smokers from the Women's Health Initiative by Moorthi, Sitapriya, Paguirigan, Amy, Itagi, Pushpa, Ko, Minjeong, Pettinger, Mary, Hoge, Anna Ch, Nag, Anwesha, Patel, Neil A, Wu, Feinan, Sather, Cassie, Levine, Kevin M, Fitzgibbon, Matthew P, Thorner, Aaron R, Anderson, Garnet L, Ha, Gavin, Berger, Alice H

Get full text

A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (CLL) or Small... by Parikh, Sameer A., Muchtar, Eli, Laplant, Betsy, Ding, Wei, Ailawadhi, Sikander, Koehler, Amber, Call, Timothy G., Kenderian, Saad S., Leis, Jose F., Fonder, Amie, Shi, Min, Chanan-Khan, Asher A., Pettinger, Adam, Witzig, Thomas E., Thompson, Carrie A., Villasboas, Jose C, Sholes, Jessica M, Hanson, Curtis A., Braggio, Esteban, Medina, Kay L., Slager, Susan L., Kay, Neil E.

Get full text

Scoping Potential Routes to UK Civil Unrest via the Food System: Results of a Structured Expert Elicitation by Jones, Aled, Bridle, Sarah, Denby, Katherine, Bhunnoo, Riaz, Morton, Daniel, Stanbrough, Lucy, Coupe, Barnaby, Pilley, Vanessa, Benton, Tim, Falloon, Pete, Matthews, Tom K, Hasnain, Saher, Heslop-Harrison, John S, Beard, Simon, Pierce, Julie, Pretty, Jules, Zurek, Monika, Johnstone, Alexandra, Smith, Pete, Gunn, Neil, Watson, Molly, Pope, Edward, Tzachor, Asaf, Douglas, Caitlin, Reynolds, Christian, Ward, Neil, Fredenburgh, Jez, Pettinger, Clare, Quested, Tom, Cordero, Juan Pablo, Mitchell, Clive, Bewick, Carrie, Brown, Cameron, Brown, Christopher, Burgess, Paul J, Challinor, Andy, Cottrell, Andrew, Crocker, Thomas, George, Thomas, Godfray, Charles J, Hails, Rosie S, Ingram, John, Lang, Tim, Lyon, Fergus, Lusher, Simon, MacMillan, Tom, Newton, Sue, Pearson, Simon, Pritchard, Sue, Sanders, Dale, Sanderson Bellamy, Angelina, Steven, Megan, Trickett, Alastair, Voysey, Andrew, Watson, Christine, Whitby, Darren, Whiteside, Kerry

Get full text

Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab by Zent, Clive S., Wu, Wenting, Bowen, Deborah A., Hanson, Curtis A., Pettinger, Adam M., Shanafelt, Tait D., Kay, Neil E., Leis, Jose F., Call, Timothy G.

Get full text

Circulating markers of cellular immune activation in pre-diagnostic human serum in relation to lung cancer risk in the Lung Cancer Cohort Consortium (LC3) by Huang, Joyce Yongxu, Larose, Tricia L., Wang, Renwei, Fanidi, Anouar, Alcala, Karine, Stevens, Victoria L., Weinstein, Stephanie J., Albanes, Demetrius, Caporaso, Neil, Purdue, Mark, Zeigler, Regina, Freedman, Neal, Lan, Qin, Prentice, Ross, Pettinger, Mary, Thomsen, Cynthia A., Cai, Qiuyin, Wu, Jie, Blot, William J., Shu, Xiao-Ou, Zheng, Wei, Arslan, Alan A., Zeleniuch-Jacquotte, Anne, Le Marchand, Loïc, Wilkens, Lynn R., Haiman, Christopher A., Zhang, Xuehong, Stampfer, Meir, Smith-Warner, Stephanie, Han, Jiali, Giles, Graham G, Hodge, Allison M, Severi, Gianluca, Johansson, Mikael, Grankvist, Kjell, Langhammer, Arnulf, Hveem, Kristian, Xiang, Yong-Bing, Li, Hong-Lan, Gao, Yu-Tang, Visvanathan, Kala, Bolton, Judy Hoffman, Ueland, Per M, Midttun, Øivind, Ulvik, Arve, Buring, Julie E., Lee, I-Min, Sesso, Howard D., Gaziano, J. Michael, Manjer, Jonas, Relton, Caroline, Koh, Woon-Puay, Brennan, Paul, Johansson, Mattias, Yuan, Jian-Min

Get full text

Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab with or without Concurrent Avastin for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL) by Shanafelt, Tait D., LaPlant, Betsy R., Call, Timothy G, Nikcevich, Daniel, Leis, Jose F., Ding, Wei, Pettinger, Adam, Van Dyke, Daniel L., Jelinek, Diane F., Hanson, Curtis A., Kay, Neil E.

Get full text

Addition of GM-CSF Does Not Improve Response to Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab and Rituximab by Zent, Clive S., Wu, Wenting, Bowen, Deborah A., Hanson, Curtis A., Pettinger, Adam M., Shanafelt, Tait D., Kay, Neil E., Leis, Jose F., Call, Timothy G.

Get full text